the [ 131i ] ethiodol was distributed predominantly in the liver ( 70-90 % ) and lungs ( 10-20 % ) and was selectively concentrated and retained in the patients with massive and multinodular hepatomas with approximately 10 % of the administered activity localizing in tumor .
C0023884
liver
C2239176
hepatomas